Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2004 (No. 1)

Administered by Department of Health, Disability and Ageing

Legislation au C2011L00009 Not in force Legislative Instrument

Legislation content

Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2004 (No. 1)

I, JOHN MENDOZA, Chief Executive Officer of the Australian Sports Drug Agency, make these Orders under regulation 7B of the Australian Sports Drug Agency Regulations 1999.

Dated                             27 July 2004

 

JOHN MENDOZA

Chief Executive Officer

 

1 Name of Orders

  These Orders are the Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2004 (No. 1).

2 Commencement

  These Orders commence on 30 July 2004.

3 Amendment of Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000

  Schedule 1 amends the Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000.

Schedule 1 Amendments

(section 3)

 

[1] Reader’s guide, Definitions, after paragraph 5

insert

5A   Section 4A of the Act provides that tampering with a sports drug matter includes an attempt to tamper with that matter.

[2] Reader’s guide, Overview of the drug testing legislative scheme, paragraph 7

omit

ask competitors to give biological or breath samples and,

insert

ask competitors to provide information about their whereabouts, to give biological or breath samples, and,

[3] Reader’s guide, Overview of the drug testing legislative scheme, paragraph 9

omit

on the relevant Register of Notifiable Events.

insert

on the relevant Register of Notifiable Events. The Agency will also enter details of a competitor’s failure to provide information about his or her whereabouts, or when a competitor has deliberately evaded an attempt by the Agency to make a request to take a sample, or when a competitor has tampered with a sample or any part of the process by which samples are requested, collected, handled tested and managed, or when, because of a competitor’s failure to provide information about his or her whereabouts, the Agency was not able to make a request to take a sample.

[4] Section 41, note 1

omit

section 14

insert

section 2

[5] Sections 42 and 43

substitute

42 Details to be entered on Register

 (1) This section applies for the following provisions of the Regulations:

 (a) paragraph 27 (2) (c);

 (b) paragraph 28 (2) (c);

 (c) paragraph 29 (2) (c);

 (d) paragraph 30 (2) (c).

 (2) In addition to the competitor’s name, the Agency must enter the following details on the Scheme B register:

 (a) the following statement, as relevant:

 (i) the competitor has failed to comply with a request for a sample;

 (ii) the competitor has returned a positive test result;

 (iii) the competitor has failed to comply with a request that the competitor keep the Agency informed of where the competitor could be found;

 (iv) the competitor missed a test, or failed to provide a sample, because of a failure by the competitor to comply with a request that the competitor keep the Agency informed of where the competitor could be found;

 (v) the competitor has deliberately evaded receiving a request for a sample;

 (vi) the competitor has tampered with a sports drug matter;

 (b) for a matter other than returning a positive test result a statement that the Agency has decided that the competitor did not have reasonable cause for the relevant matter in paragraph (a);

 (c) the competitor’s date of birth and, if the competitor is under 18 on the day the request is made, a statement to that effect;

 (d) the sport in relation to which the sample was requested;

 (e) the date specified by the Agency for collection of the sample;

 (f) if the Agency asked a sporting administration body, under paragraph 17ZC (1) (a) of the Act, to arrange for the competitor to be asked to give the sample — the name of the sporting administration body;

 (g) the State, Territory or country in which the request was made;

 (h) the reason why the sample was requested;

 (i) the date on which the sample (if any) was given;

 (j) the name of any sporting administration body to which the Agency has given, or intends to give, written notice about the entry under regulation 32;

 (k) the details of any action taken by any sporting administration body in relation to the matter.

Note 1   For the meaning of positive test result, see section 2 of the Act.

Note 2   For the schedule of drugs and doping methods for Scheme B, see section 44.

Note 3   Section 12 of the Act provides that, for the purposes of Part 3 of the Act, a competitor fails to comply with a request by the Agency to provide a sample if:

(a) the competitor fails to provide a sample as required by the scheme; or

(b) the competitor fails to complete or sign any form required by the scheme to be completed or signed by the competitor; or

(c) after providing the sample, the competitor:

 (i) fails to do anything in relation to the sample that is required by the scheme to be done by the competitor; or

 (ii) does something in relation to the sample that the scheme requires the competitor not to do.

 (3) If the competitor has returned a positive test result, the Agency must also enter the following details on the Scheme B register:

 (a) a statement to the effect that the Agency has decided, under paragraph 29 (1) (h) or 30 (1) (i) of the Regulations, that the positive test result:

 (i) is valid; and

 (ii) must be entered on the Scheme B register;

 (b) the reason why the Agency decided to make the entry on the Scheme B register, that includes:

 (i) the name and class (if any) of the relevant scheduled drug or doping method detected that caused the positive test result and any other drug or doping method detected by the test; and

 (ii) if the schedule of drugs and doping methods for Scheme B sets out a permitted level for the drug or doping method detected for the sport in relation to which the competitor was asked for a sample — the fact that the permitted level is exceeded.

Note 1   For the meaning of positive test result, see section 2 of the Act.

Note 2   For the schedule of drugs and doping methods for Scheme B, see section 44.

 

Overview

The Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2004 (No. 1) were enacted to amend the Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000. These Orders were made under the authority of regulation 7B of the Australian Sports Drug Agency Regulations 1999 by John Mendoza, the Chief Executive Officer of the Australian Sports Drug Agency. They came into effect on 30 July 2004. The purpose of these amendments is to enhance the regulatory framework surrounding drug testing in Australian sports, particularly within Scheme B. This includes clarifying and expanding the scope of what constitutes tampering with a sports drug matter, which now includes any attempt to tamper, and reinforcing the requirement for competitors to provide information about their whereabouts. Additionally, the amendments aim to ensure comprehensive record-keeping by the Agency, including the entry of various details on the Scheme B register related to competitors' compliance and drug test outcomes.

Scope and Application

The Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2004 (No. 1) amends the Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000 to enhance the drug testing procedures and record-keeping requirements for sports competitors in Australia. These Orders apply to sports competitors who are subject to drug testing under Scheme B of the Australian Sports Drug Agency Act 1999. The amendments extend to requiring the Australian Sports Drug Agency to enter specific details into the Scheme B register, including failures to comply with requests for samples, evasion of sample requests, tampering with drug testing processes, and missed tests due to non-compliance with whereabouts reporting. These Orders came into effect on 30 July 2004 and apply across Australia, encompassing all states and territories. The amendments do not specify exclusions or thresholds but focus on ensuring comprehensive record-keeping of drug testing incidents. Additionally, the application and scope of these Orders can be further extended or restricted through subordinate instruments made under the Australian Sports Drug Agency Regulations 1999.

Key Provisions

The Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2004 (No. 1) introduce significant changes to the existing drug testing scheme for sports competitors under the Australian Sports Drug Agency Regulations 1999. The Orders, which came into effect on 30 July 2004, amend the Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000. These amendments are detailed in Schedule 1, which adjusts various aspects of the drug testing procedures and the responsibilities of the Australian Sports Drug Agency (the Agency). The main operative sections of the Orders include the addition of new provisions regarding the information competitors must provide and the details the Agency must record on the Scheme B register. Specifically, Section 4A of the Act now includes an attempt to tamper with a sports drug matter as an act of tampering. Additionally, Section 42 of the Regulations mandates that the Agency enter specific details on the Scheme B register, including the competitor’s failure to comply with requests for samples, their failure to inform the Agency of their whereabouts, instances of deliberate evasion of sample requests, and instances of tampering with the sample collection process. Furthermore, Section 43 outlines the specific details that must be recorded in the Scheme B register, such as the competitor's name, date of birth, the sport in question, and the reason for the sample request, among others. The Orders impose several obligations on the parties involved. Competitors are now required to provide information about their whereabouts to facilitate drug testing, which includes making themselves available for sample collection. The Agency, in turn, is mandated to record detailed information on the Scheme B register whenever a competitor fails to comply with the drug testing scheme or engages in prohibited activities. The Agency must also enter specific details about any positive test results, including the substances detected and whether any permitted levels were exceeded. These obligations ensure transparency and accountability within the drug testing process. Failure to comply with the provisions of these Orders can result in significant consequences. While the Orders themselves do not explicitly outline specific penalties for breaches, violations of the Australian Sports Drug Agency Act 1999 and its Regulations can lead to substantial civil and criminal penalties. For instance, tampering with a sports drug matter or failing to comply with drug testing requirements can result in fines and, in some cases, imprisonment. The penalties for such offences can vary, but they are designed to deter non-compliance and uphold the integrity of sports competitions.

Legal classification tags

Area of Law
Sport Law
Instrument
Legislative Instrument
Concepts
Commencement Provisions
Regulatory Standards
Reporting & Disclosure Obligations
Catchwords
Register of Notifiable Events

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.